Product image of Mycophenolsäure Accord (Mycophenolic Acid) supplied by GNH India

Mycophenolsäure Accord

Active Ingredient:
Mycophenolic Acid
Origin:
EU

Mycophenolsäure Accord (Mycophenolic Acid)

Mycophenolic Acid, the active ingredient in Mycophenolsäure Accord, is an immunosuppressant presented as an oral formulation for oral use. It is used to prevent organ transplant rejection and to treat selected autoimmune diseases by inhibiting lymphocyte proliferation in adult patients.

GNH India supplies Mycophenolsäure Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand. Customers benefit from reliable logistics, comprehensive documentation, and responsive technical support throughout the supply chain.

Manufacturer / TM Owner

Accord Healthcare B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Mycophenolic Acid is an immunosuppressive agent used in transplantation and autoimmune disease pathways.
  • Organ transplant rejection: reduces the risk of acute rejection by suppressing T‑cell activity.
  • Kidney transplant: helps maintain graft function and prolong survival of the transplanted kidney.
  • Autoimmune diseases: controls disease activity in conditions such as lupus nephritis by limiting lymphocyte proliferation.

How It Works

  • Mycophenolic Acid selectively inhibits inosine monophosphate dehydrogenase, the key enzyme for de novo guanosine nucleotide synthesis in lymphocytes. By depleting guanosine pools, it impairs DNA synthesis and cell division, leading to reduced proliferation of B and T lymphocytes while sparing other cell types that can utilize salvage pathways. This targeted immunosuppression underlies its efficacy in preventing graft rejection and treating autoimmune disorders.

Side Effects

Mycophenolic Acid may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Headache

Serious or Rare Side Effects

  • Leukopenia or other bone‑marrow suppression
  • Severe or opportunistic infections
  • Elevated liver enzymes or hepatitis

Precautions & Warnings

Use of Mycophenolic Acid requires careful monitoring and patient education.

  • Monitor blood counts: perform regular CBC to detect leukopenia or anemia.
  • Assess renal function: check serum creatinine and eGFR periodically.
  • Evaluate liver enzymes: conduct periodic LFTs for hepatotoxicity.
  • Avoid live vaccines: immunosuppression increases risk of vaccine‑derived infection.
  • Pregnancy risk: use only if clearly needed; safety category unknown.
  • Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Avoid Interactions

Mycophenolic Acid can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid)

  • Azathioprine: combined use markedly increases myelosuppression.
  • Cyclosporine: may raise mycophenolic acid plasma concentrations.
  • Tacrolimus: can lead to elevated exposure and toxicity.

Moderate Interactions (Monitor Closely)

  • NSAIDs: may impair renal function when combined.
  • Rifampin: induces metabolism, reducing mycophenolic acid levels.
  • Cholestyramine: binds drug in gut, decreasing absorption.
  • ACE inhibitors or ARBs: monitor renal parameters due to additive nephrotoxic potential.

Frequently Asked Questions

Mycophenolsäure Accord contains mycophenolic acid, an immunosuppressant prescribed to prevent rejection after organ transplantation and to manage certain autoimmune diseases by reducing the activity of lymphocytes.

Mycophenolic acid blocks inosine monophosphate dehydrogenase, an enzyme essential for making guanosine nucleot‑ides in lymphocytes. This limits DNA synthesis, curbing the proliferation of B‑ and T‑cells and thereby dampening the immune response.

The appropriate dose is determined by the prescribing clinician based on the patient’s condition, weight, renal function and other individual factors. Dosage regimens are not standardized and should follow the prescriber’s instructions.

Safety data are limited; the pregnancy category is unknown. The drug should only be used during pregnancy or lactation if the potential benefits outweigh the risks, and this decision must be made by a qualified healthcare professional.

Enquiries are submitted via the product page on gnhindia.com, where you specify the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mycophenolic acid differs from calcineurin inhibitors such as cyclosporine by targeting nucleotide synthesis rather than calcium‑dependent pathways. This results in a distinct side‑effect profile and may be preferred when clinicians seek a non‑calcineurin‑based regimen.

Store the product at ambient temperature, preferably below 25 °C. Keep it in the original container, protect it from moisture and direct sunlight, and ensure the packaging remains tightly sealed until use.

The medication is taken orally, usually as tablets or capsules, with or without food as directed by the prescriber. Swallow the dose whole; do not crush, split or chew unless specifically instructed.

Serious concerns include bone‑marrow suppression leading to leukopenia or anemia, opportunistic infections due to immune suppression, and potential liver injury. Patients should be monitored regularly for blood‑count changes and signs of infection.

Patients with known hypersensitivity to mycophenolic acid or any component of the formulation should avoid the drug. It is also contraindicated in individuals with severe, uncontrolled infections or active malignancy unless the benefits clearly outweigh the risks.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Mycophenolic Acid

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT